Elena Wolff‐Holz
Biocon (Switzerland)(CH)Biocon (India)(IN)
Publications by Year
Research Areas
Biosimilars and Bioanalytical Methods, Pharmaceutical studies and practices, Pharmaceutical Economics and Policy, Health Systems, Economic Evaluations, Quality of Life, CAR-T cell therapy research
Most-Cited Works
- → Biosimilars: the science of extrapolation(2014)294 cited
- → Interchangeability of Biosimilars: A European Perspective(2017)172 cited
- → Evolution of the EU Biosimilar Framework: Past and Future(2019)121 cited
- → Equivalence of complex drug products: advances in and challenges for current regulatory frameworks(2017)84 cited
- → Safety, Immunogenicity and Interchangeability of Biosimilar Monoclonal Antibodies and Fusion Proteins: A Regulatory Perspective(2021)82 cited
- → Regulatory Evaluation of Biosimilars: Refinement of Principles Based on the Scientific Evidence and Clinical Experience(2022)35 cited
- → Identifiability of Biologicals in Adverse Drug Reaction Reports Received From European Clinical Practice(2018)34 cited
- → A Data Driven Approach to Support Tailored Clinical Programs for Biosimilar Monoclonal Antibodies(2022)26 cited
- → Do the Outcomes of Clinical Efficacy Trials Matter in Regulatory Decision-Making for Biosimilars?(2023)21 cited
- → Roundtable on biosimilars with European regulators and medical societies, Brussels, Belgium, 12 January 2016(2016)15 cited